To provide compounds useful as inhibitors of protein kinases.
The present invention relates to compounds useful as inhibitors of protein kinases, particularly of JAK family kinases. The invention also provides pharmaceutically acceptable compositions comprising the compounds and methods of using the compositions in the treatment of various diseases, conditions, or disorders. These compounds, and pharmaceutically acceptable compositions thereof, are useful for treating or lessening the severity of a variety of disorders, including proliferative disorders, cardiac disorders, neurodegenerative disorders, autoimmune disorders, conditions associated with organ transplantation, inflammatory disorders, or immunologically mediated disorders in a patient.
MESSERSMITH DAVID
MALTAIS FRANCOIS
GAO HUAI
WANG TIANSHENG
CAO JINGRONG
DUFFY JOHN
MARTINEZ-BOTELLA GABRIEL
FORSTER CORNELIA
MARONE VALERIE
WANNAMAKER MARION
SALITURO FRANCESCO
PIERCE ALBERT
FARMER LUC
JP2002518394A | 2002-06-25 | |||
JP2003518123A | 2003-06-03 |
WO2005068468A2 | 2005-07-28 | |||
WO2004072063A1 | 2004-08-26 | |||
WO2007070514A1 | 2007-06-21 |
Natsuki Morishita